Printer Friendly
The Free Library
5,670,416 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Pharmaceuticals and Healthcare Report Q2 2008: Independent Forecasts and Competitive Intelligence on Zimbabwe's Pharmaceuticals and Healthcare Industry.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/3b8522/zimbabwe_pharmaceu) has announced the addition of the "Zimbabwe Pharmaceuticals and Healthcare Report Q2 2008" report to their offering.

The Zimbabwe Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Zimbabwes pharmaceuticals and healthcare industry.

Zimbabwe's pharmaceutical sector continues to struggle under the weight of international sanctions International sanctions are actions taken by countries against others for political reasons, either unilaterally or multilaterally.

There are three types of sanctions.
  • Diplomatic sanctions - the reduction or removal of diplomatic ties, such as embassies.
 and hyperinflation Hyperinflation

Extremely rapid or out of control inflation.

Notes:
There is no precise numerical definition to hyperinflation. This is a situation where price increases are so out of control that the concept of inflation is meaningless.
. We estimate the market to have been worth US$4.5mn in 2007 - down 9% on its 2006 value. Despite uncertainties surrounding the economic climate making long term drug market forecasts problematic, we expect the market to shrink further to US$3.7mn by 2012, taking into account thenegative real GDP Real GDP

This inflation-adjusted measure that reflects the value of all goods and services produced in a given year, expressed in base-year prices. Often referred to as "constant-price", "inflation-corrected" GDP or "constant dollar GDP".
 growth widely expected for the economy as a whole.

A shortage of foreign currency placed severe limits on the ability of pharmacies This article is a list of major pharmacies (also known as chemists and drugstores) by country. Australia
Pharmacies in Australia are mostly independently-owned by pharmacists, often operated as franchises of retail brands offered by the three major
 to import drugs during the second half of 2007. According to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 reports in the local media, around half of drugs were out of stock in pharmacies surveyed, while those that were available had risen to prices that were multiples of local workers' salaries.

Meanwhile, Zimbabwe's manufacturing industry is suffering from similar constraints CONSTRAINTS - A language for solving constraints using value inference.

["CONSTRAINTS: A Language for Expressing Almost-Hierarchical Descriptions", G.J. Sussman et al, Artif Intell 14(1):1-39 (Aug 1980)].
 - with a lack of foreign currency reducing the volume of raw materials that can be imported. Problems at home have made exports a vital source of income and foreign currency. In this regard, CAPS Holdings continues to lead the way with exports to South Africa South Africa, Afrikaans Suid-Afrika, officially Republic of South Africa, republic (2005 est. pop. 44,344,000), 471,442 sq mi (1,221,037 sq km), S Africa. , Mozambique and Botswana. Meanwhile, Varichem Labs found another source of foreign currency - the UN Development Programme (UNDP UNDP United Nations Development Programme
UNDP Unión Nacional para la Democracia y el Progreso (National Union for Democracy and Progress) 
) - which supported a US$2.1mn upgrade of its antiretroviral antiretroviral /an·ti·ret·ro·vi·ral/ (-ret´ro-vi?ral) effective against retroviruses, or an agent with this quality.

an·ti·ret·ro·vi·ral
adj.
 (ARV ARV
abbr. Bible
American Revised Version

ARV n abbr (= American Revised Version) → traducción americana de la Biblia

ARV n abbr (=
) manufacturing plant completed in January 2008 that is expected to ensure World Health Organisation (WHO) compliance.

In BMI's updated business environment ratings for the Middle East and Africa, Zimbabwe scored 15 out of a possible 100 putting it in last place out of 14 markets surveyed. Its poor showing takes into account factors including a small, contracting market, unfavourable regulatory environment and challenging economic and political situation.

Fees in the healthcare sector have struggled to keep pace with inflation. Insurance in particular has suffered because premiums and benefits levels set in advance have been eroded e·rode  
v. e·rod·ed, e·rod·ing, e·rodes

v.tr.
1. To wear (something) away by or as if by abrasion: Waves eroded the shore.

2. To eat into; corrode.
 by rises in health fees. Meanwhile, the economic crisis seems to have put pay to any chance of a national health insurance scheme, meaning that out of pocket spending is likely to continue to increase as a proportion of health expenditure.

Key Topics Covered:
Executive Summary
Zimbabwe Pharmaceuticals And Healthcare Industry SWOT
Zimbabwe Political SWOT
Zimbabwe Economic SWOT
Zimbabwe Business Environment SWOT
Pharmaceutical Business Environment Ratings
Regional Pharma Business Environment Ratings
Limits Of Potential Returns
Risks To Realisation Of Returns
Zimbabwe - Market Summary
Regulatory Regime
Intellectual Property Developments
Pricing And Reimbursement Issues
Public Drug Procurement
Industry Developments.
Health Profile
HIV/AIDS Crisis
Recent Regional HIV/AIDS Developments
Healthcare System
Healthcare Funding
Healthcare Staff
Pharmaceutical Sector
Recent Pharmaceutical Sector Developments
Traditional Medicine
Biotechnology Sector Developments
Industry Forecast Scenario
Overall Market Forecasts
Key Growth Factors - Industry
Key Growth Factors -Macroeconomic
Prescription Market Forecast
OTC Market Forecast
Generics And Patented Market Forecast
Export/Import Forecasts
Other Healthcare Data Forecasts
Key Risks To BMI Forecasts
Competitive Landscape

Company Profiles

Multinational Companies
- Ranbaxy
- Pfizer
- Novartis
- Sanofi-Aventis
- Merck & Co
- GlaxoSmithKline

Indigenous Companies
- Datlabs
- Varichem Laboratories
- CAPS Holdings

Companies Mentioned:

- Ranbaxy
- Pfizer
- Novartis
- Sanofi-Aventis
- Merck & Co
- GlaxoSmithKline
- Datlabs
- Varichem Laboratories
- CAPS Holdings


For more information visit http://www.researchandmarkets.com/research/3b8522/zimbabwe_pharmaceu
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Report
Date:Jul 14, 2008
Words:562
Previous Article:Patriot Energy Corporation dba TelTeck Solutions to be Featured in Small Cap Stock Newsletter QualityStocks Daily.
Next Article:Research and Markets: Asset Summary Report for Buckeye Partners, L.P. Oil and Chemicals Storage Operation out Now.(Company overview)
Topics:



Related Articles
Drug Prices in Zimbabwe Have Increased by 1,376% Since January 2005.
Independent Forecasts and Competitive Intelligence on South Africa's Pharmaceuticals and Healthcare Industry Provided by Comprehensive New...
New Report 'Netherlands Pharmaceuticals & Healthcare Report Q1 2008' Forecasts That OTC Drugs in the Netherlands Will Reach a Value of Us$0.89bn by...
The Drug Market in Belgium is Growing at a Reasonable Rate and Should Reach a Total Value of US$5.67Bn by 2012, According to Our Forecasts.
Jordan Pharmaceuticals and Healthcare Report Q2 2008 Provides Competitive Intelligence on This Important Industry.(Report)
Research and Markets: Kazakhstan Pharmaceuticals and Healthcare Report Q2 2008 Available Now.(Report)
Czech Republic Pharmaceuticals and Healthcare Report Q2 2008 Provides Independent Forecasts and Competitive Intelligence on Czech...
Pharmaceuticals and Healthcare Report Q3 2008: Independent Forecasts and Competitive Intelligence on The Czech Republic's Pharmaceuticals and...
Examine the Russian Pharmaceuticals and Healthcare Industry with this Essential Report, Q3 2008.(Industry overview)(Report)
The Latest Bahrain Pharmaceuticals and Healthcare Report for Q308 is Now Available - With SWOT Analysis, Forecasts and a Detailed Market...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles